Vicarious Surgical Inc.
RBOT · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -0.06 | 0.08 | -0.04 |
| FCF Yield | -30.38% | -30.29% | -15.38% | -37.82% |
| EV / EBITDA | -3.98 | -3.24 | -6.12 | -2.44 |
| Quality | ||||
| ROIC | -36.44% | -31.67% | -23.97% | -23.88% |
| Gross Margin | 0.00% | 0.00% | 50.00% | 0.00% |
| Cash Conversion Ratio | 0.94 | 1.02 | 0.76 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -14.94% | 1.63% | 5.56% | -14.93% |
| Safety | ||||
| Net Debt / EBITDA | -0.69 | -0.71 | -0.30 | -0.42 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -157.12 | -249.02 | -100.42 | -428.88 |